227.00
+2.00
+(0.89%)
At close: January 17 at 5:29:43 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
228,866.00
196,436.00
137,285.00
159,717.00
71,124.00
Investing Cash Flow
-74,502.00
-85,532.00
-70,014.00
-84,339.00
-34,959.00
Financing Cash Flow
-95,201.00
-97,036.00
-90,410.00
-48,475.00
-35,218.00
End Cash Position
137,995.00
121,645.00
108,053.00
130,286.00
102,262.00
Capital Expenditure
-76,445.00
-86,476.00
-69,434.00
-84,306.00
-33,657.00
Issuance of Debt
--
--
--
20,705.00
3,041.00
Repayment of Debt
-29,182.00
-31,421.00
-31,935.00
-40,298.00
-28,721.00
Free Cash Flow
152,421.00
109,960.00
67,851.00
75,411.00
37,467.00
12/31/2020 - 5/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EMBLA.CO Embla Medical hf
35.20
+2.33%
ALBIO.PA Biosynex SA
2.0450
-2.62%
VITR.ST Vitrolife AB (publ)
208.00
+2.26%
MCAP.ST MedCap AB (publ)
411.00
-29.98%
REG1V.HE Revenio Group Oyj
28.18
+3.00%
CNMD CONMED Corporation
67.69
+1.24%
STE STERIS plc
209.62
-0.25%
UFPT UFP Technologies, Inc.
265.04
+1.09%
SN.L Smith & Nephew plc
1,025.50
+0.39%
CHEMM.CO ChemoMetec A/S
522.00
-0.85%